# 2026-04479: Flush Those Pills: FDA Designs Opioid Trash Tech

2026-04479, Developing Specifications for In-Home Disposal Systems for Opioid Analgesics Dispensed in an Outpatient Setting; Establishment of a Public Docket; Request for Comments, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2026-03-06, effective Submit either electronic or written comments by April 6, 2026.; PRIA reads it as touching household money (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-04479
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-04479
- Title: Developing Specifications for In-Home Disposal Systems for Opioid Analgesics Dispensed in an Outpatient Setting; Establishment of a Public Docket; Request for Comments
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 91 FR 11077
- Published: 2026-03-06
- Effective: Submit either electronic or written comments by April 6, 2026.
- Comments close: 2026-04-06
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

Flush Those Pills: FDA Designs Opioid Trash Tech

## Summary

The FDA wants your ideas on safe ways to throw away leftover opioid pain meds at home to stop misuse and overdoses. This affects anyone who gets these meds from outpatient places, and the FDA is thinking about rules to make disposal systems easier and safer. You’ve got until April 6, 2026, to share your thoughts—so don’t miss out on shaping safer medicine use!

## Abstract

The Food and Drug Administration (FDA, the Agency, or we) is announcing the establishment of a docket to solicit public comment on what specifications for in-home disposal systems, if application holders are required to make them available under the Opioid Analgesic Risk Evaluation and Mitigation Strategy, would be necessary to show that these systems may mitigate the serious risks of abuse or overdose involving these medications.

## Effects PRIA read

- FDA May Require In-Home Disposal Kits: mixed, medium. The FDA is considering requiring drug application holders to make commercially available in-home disposal systems available to outpatient pharmacies and other dispensers as an additional disposal option for patients who receive opioid analgesics. If required under the Opioid Analgesic REMS, pharmac…
- Prepaid Mail-Back Envelopes Already Required: benefit, low. FDA already modified the Opioid Analgesic REMS so that, beginning March 31, 2025, application holders must make prepaid mail-back envelopes available to outpatient pharmacies and dispensers free of charge for patients to return unused opioids. Pharmacies and other dispensers can order these envelop…
- Possible Change to FDA Disposal Advice: mixed, medium. FDA currently recommends flushing some opioids when a take-back option is not available. The Agency says that if in-home disposal systems are found to mitigate abuse and overdose risks, adopting them under the REMS would be a substantial change to FDA's disposal recommendations and could permit dis…
- FDA Seeking Technical Performance Thresholds: benefit, low. FDA is asking for public comment on specific performance specifications for in-home disposal systems, including whether a system should render at least 95% (or alternatively 80%) of an opioid's active ingredient unavailable, how quickly that reduction must occur (examples given: 2, 8, or 24 hours),…
- Reports of Accidental Exposures and Misuse Risks: cost, low. FDA reviewed reports (poison center cases and social media posts) indicating some accidental pediatric exposures and user confusion with in-home disposal systems, including users mistaking systems for medication or systems malfunctioning (e.g., bags not sealing). Reported outcomes were generally mi…
- Educational Materials to Accompany Disposal Options: benefit, low. FDA expects that any future OA REMS modification to include additional safe disposal systems would be operationalized so outpatient dispensers can order the systems and that a written educational document about risks and safe disposal would be provided to the patient with each disposal option.

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2026-04479 on federalregister.gov](https://www.federalregister.gov/documents/2026/03/06/2026-04479/developing-specifications-for-in-home-disposal-systems-for-opioid-analgesics-dispensed-in-an)
- [2026-04479 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-03-06/pdf/2026-04479.pdf)

## Related
- [Previous: 2026-04478, National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice o…](https://policyrisk.com/federal-register/2026-04478)
- [Next: 2026-04481, Determination and Certification With Respect to the Child Soldiers Prevention A…](https://policyrisk.com/federal-register/2026-04481)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-04479 (as of 2026-06-08).
